{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:28:33Z","timestamp":1783034913642,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bioorg.2020.103878","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T12:47:59Z","timestamp":1587991679000},"page":"103878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold"],"prefix":"10.1016","volume":"100","author":[{"given":"Tarek S.","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim M.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia M.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama I.","family":"El-Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.M.","family":"ElKhamisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamees","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103878_b0005","doi-asserted-by":"crossref","unstructured":"S.E. Smith, Historical survey of definitions and concepts of inflammation, Springer Berlin Heidelberg, 1978, pp. 1\u20134. doi:10.1007\/978-3-642-66888-3_1.","DOI":"10.1007\/978-3-642-66888-3_1"},{"key":"10.1016\/j.bioorg.2020.103878_b0010","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2020.103878_b0015","first-page":"1551","article-title":"Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases","volume":"37","author":"Schroeder","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.bioorg.2020.103878_b0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2165\/00003495-200363060-00001","article-title":"Sturkenboom, Nonsteroidal anti-inflammatory drugs and heart Failure","volume":"63","author":"Bleumink","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2020.103878_b0025","doi-asserted-by":"crossref","unstructured":"W.L. Smith, D.L. Dewitt, Prostaglandin endoperoxide H synthases-1 and -2, Academic Press, 62 (1996) 167\u2013215. doi.org\/10.1016\/S0065-2776(08)60430-7.","DOI":"10.1016\/S0065-2776(08)60430-7"},{"key":"10.1016\/j.bioorg.2020.103878_b0030","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1056\/NEJM199209103271101","article-title":"Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs","volume":"327","author":"Allison","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2020.103878_b0035","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1572-0241.2000.02194.x","article-title":"Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor","volume":"95","author":"Goldstein","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2020.103878_b0040","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.296.13.jrv60011","article-title":"Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2","volume":"296","author":"McGettigan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bioorg.2020.103878_b0045","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/BF03261999","article-title":"Individual NSAIDs and upper gastrointestinal complications","volume":"35","author":"Castellsague","year":"2012","journal-title":"Drug Saf."},{"key":"10.1016\/j.bioorg.2020.103878_b0050","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.bmcl.2015.03.022","article-title":"Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1\/COX-2 inhibitors","volume":"25","author":"Chen","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.103878_b0055","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bioorg.2016.12.008","article-title":"Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile","volume":"70","author":"Alsayed","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.103878_b0060","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1016\/j.bmc.2017.07.038","article-title":"Design, synthesis and bioactivities of celecoxib analogues or derivatives","volume":"25","author":"Zhou","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103878_b0065","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1016\/j.bmc.2003.07.005","article-title":"Design and synthesis of novel celecoxib analogues as selective cyclooxygenase-2 (COX-2) inhibitors: replacement of the sulfonamide pharmacophore by a sulfonylazide bioisostere","volume":"11","author":"Uddin","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103878_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107754","article-title":"Functional characterization of novel bumetanide derivatives for epilepsy treatment","volume":"162","author":"Auer","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2020.103878_b0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0090-9556(25)06000-3","article-title":"Identification of the urinary metabolites of 14C-bumetanide in the rat and their excretion by rats and dogs","volume":"4","author":"Kolis","year":"1976","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bioorg.2020.103878_b0080","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ejmech.2016.08.013","article-title":"Novel N-substituted indole schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: synthesis, biological activities in vitro and docking study","volume":"123","author":"Lamie","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103878_b0085","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(25)29014-0","article-title":"Anti-inflammatory and analgetic properties of 2-(6-Methoxy-2-naphthyl)-propionic acid (Naproxen)\u00ae","volume":"179","author":"Roszkowski","year":"1971","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bioorg.2020.103878_b0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000136348","article-title":"Gastric mucosal damage induced by non-steroid anti-inflammatory agents in rats of different ages","volume":"8","author":"Wilhelmi","year":"1972","journal-title":"Pharmacology"},{"key":"10.1016\/j.bioorg.2020.103878_b0095","unstructured":"Schr\u00f6dinger Release 2020-1: Induced Fit Docking Protocol; Glide, Schr\u00f6dinger, LLC, New York, NY, 2020; Prime, Schr\u00f6dinger, LLC. New York, NY, 2020."},{"issue":"2","key":"10.1016\/j.bioorg.2020.103878_b0100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.103878_b0105","doi-asserted-by":"crossref","unstructured":"R.G. Kurumbail, A.M. Stevens, J.K. Gierse, J.J. McDonald, R.A. Stegeman, J.Y. Pak, D. Gildehaus, J.M. iyashiro, T.D. Penning, K. Seibert, P.C. Isakson, W.C. Stallings, Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents, Nature 384 (1996) 644\u2013648. doi:10.1038\/384644a0.","DOI":"10.1038\/384644a0"},{"key":"10.1016\/j.bioorg.2020.103878_b0110","first-page":"655","article-title":"Selective COX-2 Inhibitors: a review of their structure-activity relationships","volume":"10","author":"Zarghi","year":"2011","journal-title":"Iran J. Pharm. Res."},{"key":"10.1016\/j.bioorg.2020.103878_b0115","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJM199710303371807","article-title":"Corticosteroid therapy in severe illness","volume":"337","author":"Lamberts","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2020.103878_b0120","unstructured":"Desmond R. Laurence, A.L. Bacharach, Evaluation of drug activities: pharmacometrics, Academic Press, 1964."},{"key":"10.1016\/j.bioorg.2020.103878_b0125","unstructured":"BIOvIA, D. S. Discovery studio modeling environment. San Diego, Dassault Systemes, Release, 4. 2020."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819317651?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819317651?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:59:55Z","timestamp":1758614395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819317651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":25,"alternative-id":["S0045206819317651"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103878","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103878"}}